SINAGRA, Gianfranco
 Distribuzione geografica
Continente #
NA - Nord America 1.915
AS - Asia 1.493
EU - Europa 818
SA - Sud America 368
AF - Africa 36
OC - Oceania 4
Continente sconosciuto - Info sul continente non disponibili 3
Totale 4.637
Nazione #
US - Stati Uniti d'America 1.842
SG - Singapore 556
CN - Cina 356
BR - Brasile 323
HK - Hong Kong 250
IT - Italia 176
DE - Germania 156
VN - Vietnam 111
FI - Finlandia 107
UA - Ucraina 74
RU - Federazione Russa 73
GB - Regno Unito 68
TR - Turchia 62
CA - Canada 39
IN - India 39
BD - Bangladesh 35
IE - Irlanda 34
FR - Francia 23
MX - Messico 22
JP - Giappone 21
PL - Polonia 19
SE - Svezia 15
ZA - Sudafrica 15
ES - Italia 14
AR - Argentina 12
AT - Austria 12
IQ - Iraq 11
CZ - Repubblica Ceca 10
NL - Olanda 10
MA - Marocco 9
EC - Ecuador 8
SA - Arabia Saudita 8
LT - Lituania 7
PK - Pakistan 6
UZ - Uzbekistan 6
VE - Venezuela 6
AE - Emirati Arabi Uniti 5
KE - Kenya 5
AZ - Azerbaigian 4
BG - Bulgaria 4
BO - Bolivia 4
PH - Filippine 4
PY - Paraguay 4
BE - Belgio 3
CH - Svizzera 3
CL - Cile 3
CO - Colombia 3
EG - Egitto 3
JO - Giordania 3
LK - Sri Lanka 3
NZ - Nuova Zelanda 3
PA - Panama 3
PE - Perù 3
CR - Costa Rica 2
GR - Grecia 2
ID - Indonesia 2
IL - Israele 2
JM - Giamaica 2
LV - Lettonia 2
TT - Trinidad e Tobago 2
XK - ???statistics.table.value.countryCode.XK??? 2
AL - Albania 1
AM - Armenia 1
AU - Australia 1
BY - Bielorussia 1
DO - Repubblica Dominicana 1
ET - Etiopia 1
EU - Europa 1
HN - Honduras 1
HR - Croazia 1
KG - Kirghizistan 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
MT - Malta 1
MU - Mauritius 1
MY - Malesia 1
NO - Norvegia 1
NP - Nepal 1
OM - Oman 1
PS - Palestinian Territory 1
RO - Romania 1
RW - Ruanda 1
SR - Suriname 1
SV - El Salvador 1
SY - Repubblica araba siriana 1
TN - Tunisia 1
UY - Uruguay 1
Totale 4.637
Città #
Ashburn 280
Hong Kong 249
Singapore 239
Beijing 144
Fairfield 110
New York 96
Los Angeles 78
Helsinki 77
Dallas 66
Woodbridge 66
Chandler 57
Jacksonville 56
Munich 55
Istanbul 54
Seattle 54
The Dalles 53
Ho Chi Minh City 48
Wilmington 44
Houston 40
Princeton 40
Cambridge 37
São Paulo 36
Dublin 34
Buffalo 28
Milan 27
Romola 27
Redondo Beach 26
Ann Arbor 25
San Francisco 24
Hanoi 23
Moscow 23
Shanghai 23
Orem 20
Chicago 19
Brescia 18
Montreal 18
Tokyo 18
Turku 18
Warsaw 17
Washington 17
Nanjing 16
Santa Clara 16
Frankfurt am Main 15
London 15
Boston 13
Atlanta 12
Nuremberg 12
Chennai 11
Poplar 11
Rome 11
Brooklyn 10
Dearborn 10
Denver 10
Lappeenranta 10
Stockholm 10
Belo Horizonte 9
Brno 9
Guangzhou 9
Johannesburg 9
Toronto 9
Brasília 8
Hebei 8
Rio de Janeiro 8
San Diego 8
Vienna 8
Boydton 7
Des Moines 7
Düsseldorf 7
Salvador 7
Ankara 6
City of London 6
Curitiba 6
Novara 6
Phoenix 6
Querétaro 6
Amsterdam 5
Charlotte 5
Haiphong 5
Hangzhou 5
Jinan 5
Pune 5
Sete Lagoas 5
Shenyang 5
Tashkent 5
Baghdad 4
Baku 4
Colombo 4
Da Nang 4
Dammam 4
Dhaka 4
Hải Dương 4
Juneau 4
La Paz 4
Lahore 4
Leipzig 4
Mexico City 4
Mumbai 4
Nairobi 4
Paris 4
Porto Alegre 4
Totale 2.824
Nome #
Prognostic role of β-blocker selectivity and dosage regimens in heart failure patients. Insights from the MECKI score database 144
Renal function and peak exercise oxygen consumption in chronic heart failure with reduced left ventricular ejection fraction 136
Heart failure and anemia: Effects on prognostic variables 134
Sex Profile and Risk Assessment With Cardiopulmonary Exercise Testing in Heart Failure: Propensity Score Matching for Sex Selection Bias 133
Prognostic role of atrial fibrillation in patients affected by chronic heart failure. Data from the MECKI score research group 133
Deceptive meaning of oxygen uptake measured at the anaerobic threshold in patients with systolic heart failure and atrial fibrillation 123
The metabolic exercise test data combined with Cardiac And Kidney Indexes (MECKI) score and prognosis in heart failure. A validation study 122
ANMCO / FADOI / SIAARTI / SIC / SIMG / SIMI / SIMEU Consensus Document: The clinical-diagnostic and therapeutic pathway of the patient with acute heart failure from home to discharge from the Emergency Room / Emergency Department-Acceptance 107
Cardiac Involvement in a Patient With Coronavirus Disease 2019 (COVID-19) 103
[Position paper of the Italian Society of Cardiology: The renin-angiotensin-aldosterone system (RAAS) blockade in heart failure patients - Part I: From RAAS identification to clinical trials] 92
Sacubitril/Valsartan: Updates and Clinical Evidence for a Disease-Modifying Approach 89
The prognostic value of serial troponin measurements in patients admitted for COVID-19 88
Machine learning for prediction of in-hospital mortality in coronavirus disease 2019 patients: results from an Italian multicenter study 87
[Italian Society of Cardiology-Italian Society of Nephrology Consensus document: The cardio-renal interaction in the prevention and treatment of cardiovascular diseases - Part I: From cardiovascular risk factors to the mechanisms of cardio-renal syndrome] 86
[Italian Society of Cardiology-Italian Society of Nephrology Consensus document: The cardio-renal interaction in the prevention and treatment of cardiovascular diseases - Part II: From preventive strategies to treatment of patients with cardio-renal damage] 85
[Position paper of the Italian Society of Cardiology: The renin-angiotensin-aldosterone system blockade in heart failure patients - Part II: Mechanistic effects of sacubitril/valsartan, placement in current guidelines and use in clinical practice] 84
Changes in Right Ventricular-to-Pulmonary Artery Coupling After Transcatheter Edge-to-Edge Repair in Secondary Mitral Regurgitation 83
A national survey on prevalence of possible echocardiographic red flags of amyloid cardiomyopathy in consecutive patients undergoing routine echocardiography: study design and patients characterization - the first insight from the AC-TIVE Study 83
Pulmonary embolism in patients with COVID-19: characteristics and outcomes in the Cardio-COVID Italy multicenter study 82
[Palliative inotrope therapy in advanced heart failure: organization and management] 82
Implications of atrial fibrillation on the clinical course and outcomes of hospitalized COVID-19 patients: results of the Cardio-COVID-Italy multicentre study 81
Prevalence and clinical outcomes of isolated or combined moderate to severe mitral and tricuspid regurgitation in patients with cardiac amyloidosis 76
Left ventricular wall thickness and severity of cardiac disease in women and men with transthyretin amyloidosis 76
Right ventricular to pulmonary artery coupling and outcome in patients with cardiac amyloidosis 74
Impact of heart failure on the clinical course and outcomes of patients hospitalized for COVID-19. Results of the Cardio-COVID-Italy multicentre study 74
[2022 Update on myocarditis and pericarditis following COVID-19 vaccination. Expert Opinion of the Italian Society of Cardiology] 73
[Transcatheter devices for chronic heart failure: state of the art] 72
Atrial signal amplitude predicts atrial high-rate episodes in implantable cardioverter defibrillator patients: Insights from a large database of remote monitoring trasmissions 72
[Myocarditis and pericarditis following mRNA COVID-19 vaccination. Expert opinion of the Italian Society of Cardiology] 70
Determinants of the protective effect of glucocorticoids on mortality in hospitalized patients with COVID-19: Insights from the Cardio-COVID-Italy multicenter study 70
[Rationale and significance of the Italian Network for Cardiac Amyloidosis] 70
Reduction of hospitalizations for myocardial infarction in Italy in the COVID-19 era 66
Characteristics and outcomes of patients with tricuspid regurgitation and advanced heart failure 65
[Italian Society of Cardiology (SIC) Position paper: Technical, instrumental and standards of interpretation for electrocardiography, ambulatory electrocardiographic and blood pressure monitoring in telemedicine] 63
Evolution of tricuspid regurgitation after transcatheter edge-to-edge mitral valve repair for secondary mitral regurgitation and its impact on mortality 61
OPTImal PHARMacological therapy for patients with heart failure: Rationale and design of the OPTIPHARM-HF registry 60
Value of the HFA-PEFF and H2 FPEF scores in patients with heart failure and preserved ejection fraction caused by cardiac amyloidosis 58
[Diagnostic-therapeutic care pathways for patients with cardiac amyloidosis - SIC/ANMCO Consensus document. Edited by the Italian Cardiac Amyloidosis Network (RIAC)] 58
Frailty according to the 2019 HFA-ESC definition in patients at risk for advanced heart failure: Insights from the HELP-HF registry 57
[Italian Society of Cardiology (SIC) Expert consensus document: Post-acute cardiovascular sequelae of SARS-CoV-2 infection] 57
Impact of malnutrition in patients with severe heart failure 55
Palliative care in the cardiac setting: A consensus document of the Italian Society of Cardiology (SIC) and Italian Society of Palliative Care (SICP) Joint Working Group 55
The chronic heart failure evolutions: Different fates and routes 54
Clinical and prognostic implications of heart failure hospitalization in patients with advanced heart failure 54
Apoptosis, a useful marker in the management of hot-phase cardiomyopathy? 53
Prognostic impact of the updated 2018 HFA-ESC definition of advanced heart failure: results from the HELP-HF registry 53
Clinical burden and predictors of non-cardiovascular mortality and morbidity in advanced heart failure 53
The impact of UEFA Euro 2020 football championship on Takotsubo Syndrome: Results of a multicenter national registry 53
Ischemic Etiology in Advanced Heart Failure: Insight from the HELP-HF Registry 53
Unmasking the prevalence of amyloid cardiomyopathy in the real world: results from Phase 2 of the AC-TIVE study, an Italian nationwide survey 52
Predicting survival in patients with severe heart failure: Risk score validation in the HELP-HF cohort 51
Effects of the COVID-19 pandemic on the formation of fellows in training in cardiology 50
Correction to: SARS‑CoV‑2, myocardial injury and inflammation: insights from a large clinical and autopsy study 48
Performance of risk stratification scores and role of comorbidities in older vs younger patients with pulmonary arterial hypertension 48
Detailed Assessment of the "I Need Help" Criteria in Patients With Heart Failure: Insights From the HELP-HF Registry 47
Guideline-directed medical therapy in severe heart failure with reduced ejection fraction: an analysis from the HELP-HF registry 47
Glucagon-like peptide-1 receptor agonists use and associations with outcomes in heart failure and type 2 diabetes. Data from the Swedish Heart Failure and Swedish National Diabetes Registries 45
Management of hypertrophic cardiomyopathy 43
Clinical Phenotype and Prognosis of Asymptomatic Patients With Transthyretin Cardiac Amyloid Infiltration 42
ECG/echo indexes in the diagnostic approach to amyloid cardiomyopathy: A head-to-head comparison from the AC-TIVE study 40
SGLT2 Inhibitor Therapy in Patients With Transthyretin Amyloid Cardiomyopathy 38
Role of ejection fraction in patients at risk for advanced heart failure: insights from the HELP-HF registry 38
Outcome and Morphofunctional Changes on Cardiac Magnetic Resonance in Patients With Acute Myocarditis Following mRNA COVID-19 Vaccination 38
Renin-angiotensin-aldosterone system inhibition in patients affected by heart failure: efficacy, mechanistic effects and practical use of sacubitril/valsartan. Position Paper of the Italian Society of Cardiology 36
Frequency, characteristics and risk assessment of pulmonary arterial hypertension with a left heart disease phenotype 36
SARS-CoV-2, myocardial injury and inflammation: insights from a large clinical and autopsy study 35
Aetiological phenotypes of atrial and ventricular secondary tricuspid regurgitation and their prognostic implications: insights from the CARE-TR registry 31
Phenotype and outcomes according to loop diuretic use in pulmonary arterial hypertension 27
Totale 4.704
Categoria #
all - tutte 31.390
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 31.390


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021127 0 0 0 0 0 18 3 28 16 31 16 15
2021/2022123 6 5 5 9 1 5 1 9 7 16 19 40
2022/2023238 37 23 4 4 11 52 2 23 51 3 14 14
2023/2024637 35 13 68 60 43 111 39 23 111 25 26 83
2024/20251.317 15 12 43 144 97 100 173 69 120 91 248 205
2025/20261.773 270 387 205 390 341 180 0 0 0 0 0 0
Totale 4.704